The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.

Privately-held Danish dermatology specialist LEO Pharma today revealed that the US Food and Drug Administration (FDA) has ...

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

LEO Pharma Inc. announced today that the Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream for ...

The FDA has approved delgocitinib cream as a topical treatment for moderate-to-severe chronic hand eczema (CHE) in adults, ...

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Ballerup, Denmark Saturday, July 26, 2025, 15:00 Hrs [IST] ...

LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has approved ANZUPGO ® (delgocitinib) cream (20 mg/g) for the topical treatment of ...

ACROBiosystems is breaking the chain of chronic suffering and safeguarding intestinal health. Learn how in this article.

In malaria, loss of disease tolerance results in severe complications that are challenging to manage and can result in death. This study shows that disease tolerance in malaria is mediated by ...